Objective : Bujeonghangam-tang(BH) has been used for cure of tumor as a traditional medicine. This study was carried out to clarify the effect of BH extract on hepatocellular carcinogenesis and hepatic cirrhosis induced by Diethylnitrosamine(DENA) and CCl4 in Rats.
In the 12 weeks group: The results of body were similar to 8th week groups. The activities of transaminase and ALT were significantly increased(p<0.05) in the Con compared with Nor. LDH was significantly(p<0.05) increased in the Con compared with Nor but significantly (p<0.05) decreased in the BHB. Alpha fetoprotein(AFP) were the most increased in the Con among experimental groups. The activities of superoxide dismutase(SOD) were significantly (p<0.05) increased in the Con, but the activities of catalase were not increased(p<0.05) compared with Nor. The number of hepatic p53 positive cells was increased in the Con. The results of electron microscopical observation were similar to 8th week groups. 1. . T Th he e c ch ha an ng ge es s o of f b bo od dy y w we ei ig gh ht t d du ur ri in ng g 1 12 2 w we ee ek ks s. . Nor, administered saline; Con, control group administered saline after DENA and CCl4 treatment; BHA group administered BH extract 320 / /day or BHB group administered BH extract 640 / /day during 12 weeks after DENA and CCl4 treatment. Significant differences were compared with normal at at p 0.05. n=6 F Fi ig g. . 2 2C C. . T Th he e c ch ha an ng ge es s o of f A AL LT T a ac ct ti iv vi it ti ie es s f fr ro om m 8 8 w we ee ek ks s. . Nor, administrated saline; Con, control group administrated saline after DENA and CCl4 treatment; BHA group administrated BH extract 320 / /day or BHB group administrated BH extract 640 / /day during 8 weeks after DENA and CCl4 treatment. Significant differences were compared with normal/control at *p 0.05/ # p 0.05. All values are mean S.E. (n=6). F Fi ig g. . 5 5A A. . T Th he e c ch ha an ng ge es s o of f a al lp ph ha a f fe et to op pr ro ot te ei in n f fr ro om m 8 8 w we ee ek ks s g gr ro ou up ps s. . Nor, administrated saline; Con, control group administrated saline after DENA and CCl4 treatment; BHA group administrated BH extract 320 / /day or BHB group administrated BH extract 640 / /day during 8 weeks after DENA and CCl4 treatment. Significant differences were compared with normal/control at *p 0.05/ # p 0.05. All values are mean S.E. (n=6). 2 2010 6 28 F Fi ig g. . 6 6A A. . T Th he e e ef ff fe ec ct ts s o of f B BH H e ex xt tr ra ac ct t o on n S SO OD D a ac ct ti iv vi it ti ie es s i in n t th he e D DE EN NA A a an nd d C CC Cl l4 4--i in nd du uc ce ed d l li iv ve er r i in nj ju ur ry y. . Blood were collected 8 weeks after DENA and CCl4 treatment. Nor, administered saline; Con, control group administered saline after DENA and CCl4 treatment; BHA, BH extract 320 / /day administered group; BHB, BH extract 640 / /day administered group during 8 weeks after DENA and CCl4 treatment. Significant differences were compared with normal at *p 0.05. All values are mean S.E. (n=6).
F Fi ig g. . 6 6B B. . T Th he e e ef ff fe ec ct ts s o of f B BH H e ex xt tr ra ac ct t o on n S SO OD D a ac ct ti iv vi it ti ie es s i in n t th he e D DE EN NA A a an nd d C CC Cl l4 4--i in nd du uc ce ed d l li iv ve er r i in nj ju ur ry y. . Blood were collected 12 weeks after DENA and CCl4 treatment. Nor, administered saline; Con, control group administered saline after DENA and CCl4 treatment; BHA, BH extract 320 / /day administered group; BHB, BH extract 640 / /day administered group during 12 weeks after DENA and CCl4 treatment. Significant differences were compared with normal/control at *p 0.05/ # p 0.05. All values are mean S.E. (n=6).
F Fi ig g. . 7 7A A. . T Th he e e ef ff fe ec ct ts s o of f B BH H e ex xt tr ra ac ct t o on n c ca at ta al la as se e a ac ct ti iv vi it ti ie es s i in n t th he e D DE EN NA A a an nd d C CC Cl l4 4--i in nd du uc ce ed d l li iv ve er r i in nj ju ur ry y. . Blood were collected 8 weeks after DENA and CCl4 treatment. Nor, administered saline; Con, control group administered saline after DENA and CCl4 treatment; BHA, BH extract 320 / /day administered group; BHB, BH extract 640 / /day administered group during 8 weeks after DENA and CCl4 treatment. Significant differences were compared with normal/control at *p 0.05/ # p 0.05. All values are mean S.E.(n=6).
F Fi ig g. . 5 5B B. . T Th he e c ch ha an ng ge es s o of f a al lp ph ha a f fe et to op pr ro ot te ei in n f fr ro om m 1 12 2 w we ee ek ks s g gr ro ou up ps s. . Nor, administrated saline; Con, control group administrated saline after DENA and CCl4 treatment; BHA group administrated BH extract 320 / /day or BHB group administrated BH extract 640 / /day during 12 weeks after DENA and CCl4 treatment. Significant differences were compared with normal at *p 0.05. All values are mean S.E. (n=6).
F Fi ig g. . 7 7B B. . T Th he e e ef ff fe ec ct ts s o of f B BH H e ex xt tr ra ac ct t o on n c ca at ta al la as se e a ac ct ti iv vi it ti ie es s i in n t th he e D DE EN NA A a an nd d C CC Cl l4 4--i in nd du uc ce ed d l li iv ve er r i in nj ju ur ry y. . Blood were collected 12 weeks after DENA and CCl4 treatment. Nor, administered saline; Con, control group administered saline after DENA and CCl4 treatment; BHA, BH extract 320 / /day administered group; BHB, BH extract 640 / /day administered group during 12 weeks after DENA and CCl4 treatment. Significant differences were compared with control at # p 0.05All values are mean S.E. 
